MicroRNA is awarded an Impact Factor Ranking for 2024
Business Announcement
Updates every hour. Last Updated: 4-Nov-2025 22:11 ET (5-Nov-2025 03:11 GMT/UTC)
Impact Factor Update: With MicroRNA’s addition to the Impact Factor list, 62 Bentham Science journals now hold this prestigious distinction. Current Neuropharmacology continues to lead the list with a 2024 impact factor of 5.3, followed by Recent Patents on Anti-Cancer Drug Discovery (4.1) and Current Medicinal Chemistry (3.5). Bentham Science is committed to publishing impactful research in the years to come.
A new, low-cost biosensing technology that could make rapid at-home tests up to 100 times more sensitive to viruses like COVID-19. The diagnostic could expand rapid screening to other life-threatening conditions like prostate cancer and sepsis, as well. Created by researchers at the University of California, Berkeley, the test combines a natural evaporation process called the “coffee-ring effect” with plasmonics and AI to detect biomarkers of disease with remarkable precision in just minutes.
Key findings:
--Energy-generating waves on the membranes of cancer cells may help to fuel disease progression.
--Disrupting the process could slow or halt cancer metastasis.
--Higher levels of the enzymatic waves appear linked to more severe forms of cancer, indicating that measuring them could help scientists stage cancers.
City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. This roundup highlights new insights into the cellular processes that lead to midlife weight gain, a promising new therapeutic target for acute myeloid leukemia and a revealing study that sheds light on the challenges women face in male-dominated workplaces.